INIST ST was founded as DONGWOO SYNTECH CO., LTD. in 2000
and ?has been a leader in medical supply ingredients and ingredient
?synthesizing technology development.
Based on change, innovation and affection for life, INIST ST started
the development of cerebrovascular medicine and has continued
by researching and developing excellent quality generic ingredients
and base change incrementally modified drugs and is supplying them
locally and globally.
Based on long-standing trust and skill, we develop not only multiple
first generic ingredients, but also innovative new drugs such as heart
disease contrast medium and a calcium blockade anti-cancer drug, and
now our advanced technology surpasses the high barriers of the global
market, and we are leading as a pioneer in the global market, such as
exporting more than 15 billion KRW of products to Japan, a medically